Advanced hepatocellular carcinomaProviding you the best range of regorafenib 40mg- regonat with effective & timely delivery.
Regorafenib 40Mg- Regonat
Approx. Price: Rs 8,000 / BottleGet Latest Price
|Minimum Order Quantity||3 Bottle|
|Packaging size||28 tablets per bottle|
|Treatment||Advanced hepatocellular carcinoma|
|Generic Name||Regorafenib 40mg|
(commercial name Stivarga
) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types. By 2015 it had 2 US approvals for advanced cancers.